Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
12/23/2010 | WO2010147804A1 Method for dna double-strand break repair in vitro and applications thereof |
12/23/2010 | WO2010147673A2 Single-dna molecule nanomotor regulated by photons |
12/23/2010 | WO2010147642A1 Production of triacylglycerides, fatty acids, and their derivatives |
12/23/2010 | WO2010147636A1 Herbicide resistant camelina sativa |
12/23/2010 | WO2010147464A1 Use of a cysteine synthesizing enzyme as selectable marker |
12/23/2010 | WO2010147462A2 Novel stringent selectable markers |
12/23/2010 | WO2010147452A1 A method for the assessment of cancer in a biological sample obtained from a subject |
12/23/2010 | WO2010147372A2 Primer and probe for detecting malaria plasmodium and detection method using same |
12/23/2010 | WO2010147218A1 Biomass feedstock processing method, sugar production method, ethanol production method, and lactic acid production method |
12/23/2010 | WO2010147196A1 Protein having novel prenylation enzyme activity and gene encoding same |
12/23/2010 | WO2010147171A1 Chicken-derived anti-lox-1 antibody |
12/23/2010 | WO2010147167A1 Method for positioning of probe in microarray |
12/23/2010 | WO2010147138A1 Gene encoding fatty acid elongase, and use thereof |
12/23/2010 | WO2010147111A1 Cell-free protein synthesis solution, cell-free protein synthesis kit, and protein synthesis method |
12/23/2010 | WO2010146359A1 Production of viral capsids |
12/23/2010 | WO2010146055A1 Antagonists of beta-catenin for preventing and/or treating neurodegenerative disorders |
12/23/2010 | WO2010146046A1 Hydroponic systems for generating transgenic plants |
12/23/2010 | WO2010146036A1 Novel proteases and means containing said proteases |
12/23/2010 | WO2010146026A1 Improvement of low-biomass soil dna/rna extraction yield and quality |
12/23/2010 | WO2010145846A1 Nicotiana benthamiana plants deficient in xylosyltransferase activity |
12/23/2010 | WO2010145843A1 Method for isolating nucleic acids |
12/23/2010 | WO2010145778A1 MODIFIED siNA |
12/23/2010 | WO2010125036A3 Plants having enhanced yield-related traits and a method for making the same |
12/23/2010 | WO2010124231A3 Modulation of gene expression using oligomers that target gene regions downstream of 3' untranslated regions |
12/23/2010 | WO2010121268A3 Regulation of aging by modulation of mitochondrial function |
12/23/2010 | WO2010095150A3 Nucleic acids of jatropha curcas and its applications |
12/23/2010 | WO2010082097A3 Fusion proteins the process to preparation and utilization in expression systems of recombinant proteins |
12/23/2010 | WO2010067339A3 Fusion protein capable of binding vegf-a and tnf-alpha |
12/23/2010 | WO2009099378A8 Selection of rna-aptamers as anti-malaria agents |
12/23/2010 | US20100325760 Fagopyritol synthase genes and uses thereof |
12/23/2010 | US20100325759 Protein Kinase Stress-Related Proteins and Methods of Use in Plants |
12/23/2010 | US20100325756 Plastid transformation utilizing endogenous regulatory elements |
12/23/2010 | US20100325754 Compositions and methods for modulating oxidative burst in plant transformation |
12/23/2010 | US20100325753 Plants Having Increased Yield-Related Traits and a Method For Making The Same |
12/23/2010 | US20100325752 Cytokinin Oxidase Promoter from Maize |
12/23/2010 | US20100325751 Tomato plants that exhibit resistance to botrytis cinerea |
12/23/2010 | US20100325750 Major QTLS Conferring Resistance Of Corn To Fijivirus |
12/23/2010 | US20100325748 Tomato hybrid ex01420200 and parent lines thereof |
12/23/2010 | US20100325746 Methods and sequences to suppress primate huntington gene expression in vivo |
12/23/2010 | US20100325745 Meganuclease variants cleaving a dna target sequence from the mouse rosa26 locus and uses thereof |
12/23/2010 | US20100325743 Marks as modifiers of the p53 pathway and methods of use |
12/23/2010 | US20100324829 Method of selecting hla-dp4 ligands and the applications thereof |
12/23/2010 | US20100324277 Oligomeric compounds comprising 4'-thionucleosides for use in gene modulation |
12/23/2010 | US20100324272 Pancreatic cancer genes |
12/23/2010 | US20100324258 Process for the Production of Gamma-Aminobutyric Acid |
12/23/2010 | US20100324126 Syn3 compositions and methods |
12/23/2010 | US20100324125 Proteins derived from white spot syndrome virus and uses thereof |
12/23/2010 | US20100324122 Modulation of sglt2 expression |
12/23/2010 | US20100324121 Methods and compositions for the specific inhibition of gene expression by double-stranded rna |
12/23/2010 | US20100324118 Method for the Promotion of Angiogenesis, Vascularization, or Vascular Repair or for the Inhibition of Tumor Angiogenesis |
12/23/2010 | US20100324117 Hepatitis c dsrna effector molecules, expression constructs, compositions, and methods of use |
12/23/2010 | US20100324113 Delivery Method |
12/23/2010 | US20100323974 Inhibitors of PARP Activity and Uses Thereof |
12/23/2010 | US20100323971 Cell permeable nm23 recombinant proteins, polynucleotides encoding the same, and anti-metastatic composition comprising the same |
12/23/2010 | US20100323969 Compounds Binding to P-Selectin |
12/23/2010 | US20100323967 RNA Antagonist Compounds for the Modulation of MCL-1 |
12/23/2010 | US20100323956 Glucose-regulating polypeptides and methods of making and using same |
12/23/2010 | US20100323954 Chimeric polypeptides and uses thereof |
12/23/2010 | US20100323922 siRNA targeting TATA box binding protein (TBP)-associated factor (TAF1) |
12/23/2010 | US20100323905 Vhh for the Diagnosis, Prevention and Treatment of Diseases Associated with Protein Aggregates |
12/23/2010 | US20100323448 Methods For Producing Biological Substances In Enzyme-Deficient Mutants Of Aspergillus niger |
12/23/2010 | US20100323428 Attenuated minus-stranded rna virus |
12/23/2010 | US20100323425 Detection of nucleic acid differences using combined endonuclease cleavage and ligation reactions |
12/23/2010 | US20100323424 Targeted modification of chromatin structure |
12/23/2010 | US20100323420 Regulated apoptosis |
12/23/2010 | US20100323412 Novel gene sms 44 |
12/23/2010 | US20100323408 Mutant Strains of Pseudomonas Fluorescens And Variants Thereof, Methods For Their Production, And Uses Thereof In Alginate Production |
12/23/2010 | US20100323406 Mutant dna polymerases and methods of use |
12/23/2010 | US20100323403 Polypurine tract modified retroviral vectors |
12/23/2010 | US20100323402 Udp-glucuronyl transferase and polynucleotide encoding the same |
12/23/2010 | US20100323399 Use of Trail Polypeptides to Treat Cancer |
12/23/2010 | US20100323398 Baculoviruses With Enhanced Virion Production and a Method for the Production of Baculoviruses |
12/23/2010 | US20100323397 Modified vird2 protein and its use in improved gene transfer |
12/23/2010 | US20100323385 Nitrogen independence identifies a highly malignant population of tumor stem cells |
12/23/2010 | US20100323383 Methods for in vitro differentiation of Th-17+cells |
12/23/2010 | US20100323378 Modified glucose dehydrogenase gene |
12/23/2010 | US20100323377 Biochemical markers for cvd risk assessment |
12/23/2010 | US20100323366 Methods of Selecting a Dopaminergic Neuron Proliferative Progenitor Cells Using LRP4/CORIN Markers |
12/23/2010 | US20100323356 Small rna-dependent translational regulatory system in cell or artificial cell model |
12/23/2010 | US20100323351 Tumor suppressor gene, p47ing3 |
12/23/2010 | US20100323086 Plants and seeds of spring canola variety scv218328 |
12/23/2010 | US20100323024 Puumala virus full-length m segment-based dna vaccines |
12/23/2010 | US20100322977 Biomaterials, compositions, and methods |
12/23/2010 | US20100322975 Anti-bacterial Vaccine Compositions |
12/23/2010 | US20100322974 Targeting the histone code as a bacterial strategy for selectively modulating gene expression |
12/23/2010 | US20100322965 Viral vaccine vectors |
12/23/2010 | US20100322957 Secretion-related bacterial proteins for nlrc4 stimulation |
12/23/2010 | US20100322956 Methods and substances for the treatment of alzheimer's |
12/23/2010 | US20100322955 Virulence genes, proteins, and their use |
12/23/2010 | US20100322954 Enhanced hiv-1 vaccines and methods for their use |
12/23/2010 | US20100322953 Lipidated Tumor-Associated Antigens and Immunotherapeutic Compositions |
12/23/2010 | US20100322951 Replication-proficient dsRNA capsids and uses thereof |
12/23/2010 | US20100322950 Compositions and methods for diagnosis and treatment of tumors |
12/23/2010 | US20100322946 Multispecific antibodies |
12/23/2010 | US20100322940 In vitro modification of glycosylation patterns of recombinant glycopeptides |
12/23/2010 | US20100322937 EGF receptor epitope peptides and uses thereof |
12/23/2010 | US20100322931 Anti-vegf antibodies and their uses |
12/23/2010 | US20100322930 Fibronectin-based binding molecules and their use |
12/23/2010 | US20100322929 Antigen presenting cell targeted cancer vaccines |
12/23/2010 | US20100322920 Human monoclonal antibodies against CD30 |